Shenzhen Kangtai Biological Products Co (SZSE:300601) Marketable Securities : ¥121 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Kangtai Biological Products Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Shenzhen Kangtai Biological Products Co's Marketable Securities for the quarter that ended in Mar. 2024 was ¥121 Mil.

Shenzhen Kangtai Biological Products Co's annual Marketable Securities increased from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥441 Mil) but then declined from Dec. 2022 (¥441 Mil) to Dec. 2023 (¥100 Mil).

Shenzhen Kangtai Biological Products Co Marketable Securities Historical Data

The historical data trend for Shenzhen Kangtai Biological Products Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Kangtai Biological Products Co Marketable Securities Chart

Shenzhen Kangtai Biological Products Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

2,155.14

440.83

100.02

Shenzhen Kangtai Biological Products Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															18.16	18.02	18.12	100.02	120.80

Shenzhen Kangtai Biological Products Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Shenzhen Kangtai Biological Products Co (SZSE:300601) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Shenzhen Kangtai Biological Products Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Shenzhen Kangtai Biological Products Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen Kangtai Biological Products Co (SZSE:300601) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Kangtai Biological Products Co Ltd (SZSE:300601) » Definitions » Marketable Securities

Traded in Other Exchanges

N/A

Address

No. 6 Kefa Road, Science and Technology Industrial Park, Nanshan District, Shenzhen, CHN, 518057

Website

http://www.biokangtai.com

Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.

Executives

Liu Jian Kai	Directors, executives
Tao Jin	Secretary Dong
Zheng Hai Fa	Directors, executives
Zhou Hui	Executives
Miao Xiang	Directors, executives
Wen Fei Dong	Director
Du Wei Min	Directors, executives
Lv Zhi Yun	Supervisors
Gan Jian Hui	Executives
Zhu Zheng Yu	Executives
Liu Qun	Executives
Li Tong	Executives
Yuan Li Ping	Director
Li Xiang Ming	Independent director

Shenzhen Kangtai Biological Products Co (SZSE:300601) Headlines

No Headlines